Monday, May 23, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

Cuban nasal vaccine against Covid-19 stands out in El Salvador

Cuban nasal vaccine against Covid-19 stands out in El Salvador

San Salvador, Apr 18 (Prensa Latina) The development in Cuba of Mambisa, a nasal vaccine to strengthen immunity against Covid-19, is highlighted today by Salvadoran media.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

“Cuba is about to launch an anticovid vaccine that is administered through the nose,” headlines newspaper El Mundo, which highlights the progress in clinical trials of the new vaccine candidate from the Center for Genetic Engineering and Biotechnology (CIGB).

The aforementioned newspaper reproduced the “tweet” of the CIGB on the positive results that support the use of Mambisa in the application of booster doses.

Unlike injectables, nasal vaccines increase local immunogenicity in the mucous membranes, the site of entry of the pathogen, which allows it to be neutralized early.

The Cuban health authorities are deploying an immunization campaign with the national Sovereign 02, Sovereign Plus and Abdala vaccines, and to date nearly 10 million citizens on the island have completed their vaccination schedule.

ef/mem/cmv

ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.